Abstract

Plasmodium parasites are the causative agents of malaria, a disease with wide public health repercussions. Increasing drug resistance and the absence of a vaccine make finding new chemotherapeutic strategies imperative. Components of the ubiquitin and ubiquitin-like pathways have garnered increased attention as novel targets given their necessity to parasite survival. Understanding how these pathways are regulated in Plasmodium and identifying differences to the host is paramount to selectively interfering with parasites. Here, we focus on Nedd8 modification in Plasmodium falciparum, given its central role to cell division and DNA repair, processes critical to Plasmodium parasites given their unusual cell cycle and requirement for refined repair mechanisms. By applying a functional chemical approach, we show that deNeddylation is controlled by a different set of enzymes in the parasite versus the human host. We elucidate the molecular determinants of the unusual dual ubiquitin/Nedd8 recognition by the essential PfUCH37 enzyme and, through parasite transgenics and drug assays, determine that only its ubiquitin activity is critical to parasite survival. Our experiments reveal interesting evolutionary differences in how neddylation is controlled in higher versus lower eukaryotes, and highlight the Nedd8 pathway as worthy of further exploration for therapeutic targeting in antimalarial drug design.

Highlights

  • The ubiquitin proteasome system is an ancient and highly conserved pathway essential for the regulation of many important cellular processes in eukaryotes [1])

  • Nedd8 modification of cullin ubiquitin E3 ligases is critical to the viability of eukaryotic organisms and mediates cell cycle progression and DNA damage repair

  • Research Council (NHMRC) CJ Martin Fellowship (APP1072476), the Jack Brockhoff Foundation (JBF 4186, 2016), and a Newton Fund RCUKCONFAP Grant awarded by The Medical Research Council (MRC) and Fundacão de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) (MR/M026302/1)

Read more

Summary

Introduction

The ubiquitin proteasome system is an ancient and highly conserved pathway essential for the regulation of many important cellular processes in eukaryotes [1]). It is implicated in a great number of diseases, especially cell cycle disorders such as cancer[2,3,4]. The number of ubiquitin moieties and the nature of their attachment and branching determines the fate and function of the substrate. This process is reversible and ubiquitin removal is catalyzed by a number of ubiquitin-hydrolases (DUBs). Other ubiquitin-like post-translational modifiers such as SUMO, Nedd and Apg are conjugated to and released from target proteins following a similar mechanism and using corresponding enzymes

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call